Experimental isolation and transplantation of hepatocytes with the use of antibody against interleukin-2 receptor (Daclizumab) as immunosuppressive agent

Transplantation Proceedings

Volumn 37, Issue 4, 2005, Pages 1929-1930

  Tsiolis, I ^a   Papalois, A ^b,e   Loukopoulos, I ^b   Gravvanis, A ^b   Lykoudis, E ^b   Theodossopoulou, E ^b   Chairakakis, A ^b   Dimitroulopoulos, D ^b   Sfiniadakis, I ^d   Vassiliou, I ^c   Felekouras, E ^b   Dedeilias, P ^b   Kontogiorgi, M ^b   Papadimitriou, L ^a   Papadimitriou, I ^a  

^a Henry Dynan Hospital   (Greece)

^b ELPEN Pharmaceuticals   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d ATHENS NAVAL HOSPITAL   (Greece)

^e NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; CYCLOSPORIN A; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 RECEPTOR ANTIBODY;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL ISOLATION; CHEMICAL ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFICACY; GRAFT VERSUS HOST REACTION; HEPATOCYTE TRANSPLANTATION; LIVER CELL; LIVER FAILURE; MALE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SURVIVAL;

ANIMALS; ANTIBODIES, MONOCLONAL; GRAFT SURVIVAL; HEPATOCYTES; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; LIVER FAILURE, ACUTE; MALE; MODELS, ANIMAL; RATS; RATS, INBRED LEW; RATS, WISTAR; RECEPTORS, INTERLEUKIN-2; SPLEEN; TRANSPLANTATION, HOMOLOGOUS;

EID: 20344379706     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.02.097     Document Type: Conference Paper

References (5)

1. P. Vincetti BioDrugs 11 1999 333
2. R. Whittington, D. Faulds Drugs 46 1993 446
3. T. Tanigushi, Y. Minami Cell 75 1993 5
4. A. Papalois, N. Arkadopoulos, Th. Pataryas Transpl Int 7 1994 432
5. A. Papalois, N. Arkadopoulos, G. Kostopanagiotou Transplant Proc 29 1997 2096